{"title":"Assessing the risk factors and establishing multivariable prediction models for singleton macrosomia.","authors":"Jinying Luo, Wenyan Huang, Suping Luo, Lin Deng, Lihua Lin, Qiuping Liao, Jianying Yan, Jinfu Zhou","doi":"10.3389/fmed.2025.1590283","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Fetal macrosomia is related to adverse neonatal and maternal health outcomes. Therefore, we aimed to evaluate the risk factors for macrosomia and establish multivariable prediction models to enable early identification, prevention, and mitigation of its adverse outcomes.</p><p><strong>Methods: </strong>This retrospective case-control study included 800 singleton pregnant women who delivered in 2022 at Fujian Maternity and Child Health Hospital and Quanzhou Women and Children's Hospital. They were categorized into the macrosomia [birth weight (BW) ≥ 4,000 g, <i>n</i> = 400] and non-macrosomia (BW = 2,500-3,999 g, <i>n</i> = 400) groups according to the BW of the newborns. Prediction models in singleton fetuses during mid-to-late pregnancy and before delivery were constructed.</p><p><strong>Results: </strong>Maternal height ≥ 165 cm [odds ratio (OR) = 2.303, 95% confidence interval (CI): 1.232-4.305], pre-pregnancy overweight (OR = 2.166, 95% CI: 1.119-4.195), pre-pregnancy obesity (OR = 3.189, 95% CI: 1.020-9.968), excessive gestational weight gain in the second trimester (OR = 2.083, 95% CI: 1.250-3.470), and at least two abnormal blood glucose values in the oral glucose tolerance test (OR = 5.267, 95% CI: 1.814-15.29) were identified as risk factors for macrosomia. Additionally, maternal abdominal circumference (AC) plus fundal length ≥ 140 cm (OR = 6.283, 95% CI: 3.976-9.927), fetal biparietal diameter ≥ 10 cm (OR = 3.373, 95% CI: 1.103-10.31), fetal head circumference ≥ 35 cm (OR = 3.473, 95% CI: 1.334-9.041), and fetal AC ≥ 36 cm at pre-delivery (OR = 23.46, 95% CI: 14.81-37.16) were risk factors for macrosomia.</p><p><strong>Discussion: </strong>The construction of the macrosomia prediction model in singleton fetuses during mid-to-late pregnancy and before delivery showed a strong predictive value. This study identified key high-risk factors for macrosomia during the perinatal period. The macrosomia prediction model developed here is expected to enable early identification of macrosomia, allowing for timely interventions aimed at reducing the risk of adverse perinatal outcomes.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"12 ","pages":"1590283"},"PeriodicalIF":3.1000,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12504509/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2025.1590283","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Fetal macrosomia is related to adverse neonatal and maternal health outcomes. Therefore, we aimed to evaluate the risk factors for macrosomia and establish multivariable prediction models to enable early identification, prevention, and mitigation of its adverse outcomes.
Methods: This retrospective case-control study included 800 singleton pregnant women who delivered in 2022 at Fujian Maternity and Child Health Hospital and Quanzhou Women and Children's Hospital. They were categorized into the macrosomia [birth weight (BW) ≥ 4,000 g, n = 400] and non-macrosomia (BW = 2,500-3,999 g, n = 400) groups according to the BW of the newborns. Prediction models in singleton fetuses during mid-to-late pregnancy and before delivery were constructed.
Results: Maternal height ≥ 165 cm [odds ratio (OR) = 2.303, 95% confidence interval (CI): 1.232-4.305], pre-pregnancy overweight (OR = 2.166, 95% CI: 1.119-4.195), pre-pregnancy obesity (OR = 3.189, 95% CI: 1.020-9.968), excessive gestational weight gain in the second trimester (OR = 2.083, 95% CI: 1.250-3.470), and at least two abnormal blood glucose values in the oral glucose tolerance test (OR = 5.267, 95% CI: 1.814-15.29) were identified as risk factors for macrosomia. Additionally, maternal abdominal circumference (AC) plus fundal length ≥ 140 cm (OR = 6.283, 95% CI: 3.976-9.927), fetal biparietal diameter ≥ 10 cm (OR = 3.373, 95% CI: 1.103-10.31), fetal head circumference ≥ 35 cm (OR = 3.473, 95% CI: 1.334-9.041), and fetal AC ≥ 36 cm at pre-delivery (OR = 23.46, 95% CI: 14.81-37.16) were risk factors for macrosomia.
Discussion: The construction of the macrosomia prediction model in singleton fetuses during mid-to-late pregnancy and before delivery showed a strong predictive value. This study identified key high-risk factors for macrosomia during the perinatal period. The macrosomia prediction model developed here is expected to enable early identification of macrosomia, allowing for timely interventions aimed at reducing the risk of adverse perinatal outcomes.
期刊介绍:
Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate
- the use of patient-reported outcomes under real world conditions
- the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines
- the scientific bases for guidelines and decisions from regulatory authorities
- access to medicinal products and medical devices worldwide
- addressing the grand health challenges around the world